New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Breast cancer incidence rising for young women since 1935

Breast cancer incidence rising for young women since 1935

The incidence of breast cancer for women aged 25 to 39 years has been increasing since 1935 and seems not to be related to changes in parity over time, according to a study published online March 13 i
World medicine December 11,2023
Breast cancer incidence rising for young women since 1935

Breast cancer incidence rising for young women since 1935

The incidence of breast cancer for women aged 25 to 39 years has been increasing since 1935 and seems not to be related to changes in parity over time, according to a study published online March 13 i
World medicine December 11,2023
Under reporting of data on the outcomes among older adults in cancer clinical trials

Under reporting of data on the outcomes among older adults in cancer clinical trials

by Bill Bangert,University of CincinnatiKarlynn BrintzenhofeSzoc of the College of Allied Health Sciences shows her research paper to a class of graduate students in the School of Social Work. C
World medicine December 11,2023
Under reporting of data on the outcomes among older adults in cancer clinical trials

Under reporting of data on the outcomes among older adults in cancer clinical trials

by Bill Bangert,University of CincinnatiKarlynn BrintzenhofeSzoc of the College of Allied Health Sciences shows her research paper to a class of graduate students in the School of Social Work. C
World medicine December 11,2023
Functional outcomes similar across localized prostate cancer treatments

Functional outcomes similar across localized prostate cancer treatments

(HealthDay)—Most functional differences associated with contemporary management of localized prostate cancer attenuate by five years, according to a study published in the Jan. 14 issue of theJo
World medicine December 11,2023
Functional outcomes similar across localized prostate cancer treatments

Functional outcomes similar across localized prostate cancer treatments

(HealthDay)—Most functional differences associated with contemporary management of localized prostate cancer attenuate by five years, according to a study published in the Jan. 14 issue of theJo
World medicine December 11,2023
Outcomes steadily improve for multiple myeloma treated with ASCT

Outcomes steadily improve for multiple myeloma treated with ASCT

(HealthDay)—For patients with multiple myeloma (MM) treated with autologous stem cell transplantation (ASCT), long-term outcomes have improved steadily, according to a study published in the Jan. 28 i
World medicine December 11,2023
Outcomes steadily improve for multiple myeloma treated with ASCT

Outcomes steadily improve for multiple myeloma treated with ASCT

(HealthDay)—For patients with multiple myeloma (MM) treated with autologous stem cell transplantation (ASCT), long-term outcomes have improved steadily, according to a study published in the Jan. 28 i
World medicine December 11,2023
Study examines why colon cancer is more deadly in pediatric and young adult patients

Study examines why colon cancer is more deadly in pediatric and young adult patients

byAmerican College of SurgeonsColon Cancer in Patients Under 25 Years Old: A Different Disease? Credit: American College of SurgeonsColon cancer is more likely to be lethal in children and young
World medicine December 11,2023
Study examines why colon cancer is more deadly in pediatric and young adult patients

Study examines why colon cancer is more deadly in pediatric and young adult patients

byAmerican College of SurgeonsColon Cancer in Patients Under 25 Years Old: A Different Disease? Credit: American College of SurgeonsColon cancer is more likely to be lethal in children and young
World medicine December 11,2023
Understanding off-target effects of cancer drugs could lead to new treatments

Understanding off-target effects of cancer drugs could lead to new treatments

by Professor Paul Workman,Institute of Cancer ResearchCredit: CC0 Public DomainThese days, in the era of personalized medicine, whenever researchers discover a new cancer drug they are expected
World medicine December 11,2023
Understanding off-target effects of cancer drugs could lead to new treatments

Understanding off-target effects of cancer drugs could lead to new treatments

by Professor Paul Workman,Institute of Cancer ResearchCredit: CC0 Public DomainThese days, in the era of personalized medicine, whenever researchers discover a new cancer drug they are expected
World medicine December 11,2023
Tunable bonds: A step towards targeted At-211 cancer therapy

Tunable bonds: A step towards targeted At-211 cancer therapy

byUS Department of EnergyThe binding of At-211 with mono- and diketones with different bond strengths. Credit: Jon Burns, University of Alabama at BirminghamAstatine is the least abundant elemen
World medicine December 11,2023
Tunable bonds: A step towards targeted At-211 cancer therapy

Tunable bonds: A step towards targeted At-211 cancer therapy

byUS Department of EnergyThe binding of At-211 with mono- and diketones with different bond strengths. Credit: Jon Burns, University of Alabama at BirminghamAstatine is the least abundant elemen
World medicine December 11,2023
First-ever pathology of the early phase of lung infection with the 2019 novel coronavirus (COVID-19)

First-ever pathology of the early phase of lung infection with the 2019 novel coronavirus (COVID-19)

by International Association for the Study of Lung CancerCredit: CC0 Public DomainAn international team of clinicians and researchers for the first time have described the pathology of the SARS-CoV-2,
World medicine December 11,2023
First-ever pathology of the early phase of lung infection with the 2019 novel coronavirus (COVID-19)

First-ever pathology of the early phase of lung infection with the 2019 novel coronavirus (COVID-19)

by International Association for the Study of Lung CancerCredit: CC0 Public DomainAn international team of clinicians and researchers for the first time have described the pathology of the SARS-CoV-2,
World medicine December 11,2023
Scientists make promising discovery in fight against breast cancer

Scientists make promising discovery in fight against breast cancer

byUniversity of LiverpoolMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainResearchers from the University of Liverpool have created a biomedical c
World medicine December 11,2023
Scientists make promising discovery in fight against breast cancer

Scientists make promising discovery in fight against breast cancer

byUniversity of LiverpoolMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainResearchers from the University of Liverpool have created a biomedical c
World medicine December 11,2023
Team finds cancer drug resistance genes and possibly how to limit their effects

Team finds cancer drug resistance genes and possibly how to limit their effects

bySt. Jude Children's Research HospitalLeft to right: Cheng Cheng, Ph.D., of the St. Jude Department of Biostatistics; Robert Autry, of St. Jude and a graduate student at the University of T
World medicine December 11,2023
Team finds cancer drug resistance genes and possibly how to limit their effects

Team finds cancer drug resistance genes and possibly how to limit their effects

bySt. Jude Children's Research HospitalLeft to right: Cheng Cheng, Ph.D., of the St. Jude Department of Biostatistics; Robert Autry, of St. Jude and a graduate student at the University of T
World medicine December 11,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com